Literature DB >> 7622833

The content and context of compliance.

P E Bebbington1.   

Abstract

Compliance is adherence to a prescribed and appropriate treatment, not necessarily pharmacological. Non-compliance may occur in up to 50% of patients with schizophrenia who are prescribed neuroleptics. It may be commoner in young people, particularly if male or from certain ethnic minority groups, but demographic factors are relatively unimportant. Clinical features such as positive symptoms are associated with non-compliance but the strongest clinical relationship is with a "dual diagnosis", usually with an associated alcohol abuse. Patients' and relatives' beliefs about schizophrenia and about medication are of considerable importance in determining compliance, and can be understood in terms of the "health belief model". However, a full understanding of non-compliance must take into account the relationship between patients and doctors in the context of the sick role. Several techniques for increasing compliance have been described, but they contain common elements--the provision of information within the context of a warm and equitable therapeutic relationship, preferably maintained over some time, and the use of the relationship to encourage and prompt compliance and to establish more productive views of the illness and medication. The costs of poor compliance to sufferers and to society alike are considerable, and effective ways of improving it are a crucial part of good management.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622833     DOI: 10.1097/00004850-199501005-00008

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  28 in total

1.  Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.

Authors:  K J Aitchison; J Munro; P Wright; S Smith; A J Makoff; C Sachse; P C Sham; R M Murray; D A Collier; R W Kerwin
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  Medication Discussion Questions (MedDQ): developing a guide to facilitate patient-clinician communication about heart medications.

Authors:  Linda Garavalia; Brian Garavalia; John A Spertus; Carole Decker
Journal:  J Cardiovasc Nurs       Date:  2011 Jul-Aug       Impact factor: 2.083

3.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

4.  What's in name? Psychiatric epidemiology and social psychiatry at the turn of the century.

Authors:  P Bebbington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

5.  Fostering Recovery from Life-Transforming Mental Health Disorders: A Synthesis and Model.

Authors:  Carla A Green
Journal:  Soc Theory Health       Date:  2004-11-01

6.  Psychiatric comorbidity and the long-term care of people with AIDS.

Authors:  J L Goulet; S Molde; J Constantino; D Gaughan; P A Selwyn
Journal:  J Urban Health       Date:  2000-06       Impact factor: 3.671

7.  Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.

Authors:  Mamta Sapra; Ipsit V Vahia; Pia N Reyes; Paul Ramirez; Carl I Cohen
Journal:  Schizophr Res       Date:  2008-10-11       Impact factor: 4.939

8.  Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER.

Authors:  Michael Birnbaum; Zafar Sharif
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

9.  Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers.

Authors:  Carole Decker; Linda Garavalia; Brian Garavalia; John A Spertus
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

10.  Attitudes toward medication and the clinical variables in schizophrenia: Structural equation models.

Authors:  Alessandro Rossi; Roberta Pacifico; Paolo Stratta
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.